CRISPR Therapeutics AG (CRSP) closed the most recent trading day at $38.36, moving -1.26% from the previous trading session.

VUG ETF invests in large-cap growth stocks. Check out 3 key reasons why the fund might not be a good choice from a portfolio ...

The Vanguard US Total Market Shares Index ETF (ASX: VTS) outperformed the Vanguard Australian Shares Index ETF (ASX: VAS) by ...

In a report released yesterday, Alec Stranahan from Bank of America Securities maintained a Buy rating on Crispr Therapeutics AG (CRSP – ...

Leerink Partners analyst Mani Foroohar has maintained their bullish stance on CRSP stock, giving a Buy rating on January 13.Stay Ahead of the ...

Local pastor, father to a four-year-old daughter, and educator fights cancer for the third time. Shreveport/Bossier native ...

A study concluded that the use of over-the-counter pain relievers is more effective than opioids for pain management after ...

The Office for Students with Disabilities (OSD) at PennWest Edinboro is commemorating 50 years of providing nationally renowned support services and access to educational opportunities for all.

Medical laboratories at Lawrence + Memorial and Westerly hospitals have been re-accredited by the Accreditation Committee of the College of American Pathologists. The hospitals’ medical labs are among ...

Senior Center will offer a home safety and fall screening at 1 p.m. on Tuesday, Jan. 21, at the senior center, 216 Third St. NW. An occupational therapist and physical therapist from Sanford Health ...

BridgeBio Pharma stock saw a positive improvement to its Relative Strength (RS) Rating on Tuesday, with an increase from 64 to 87. Is BridgeBio Pharma Stock A Buy? BridgeBio Pharma earns the No. 180 ...

Excellus BlueCross BlueShield recently announced the recipients of Health Equity Innovation Awards, designed to support community programs and services that focus on combating racial and ethnic health ...